Levitee Labs Inc. (C:LVT)
Business Focus: Special Foods & Wellbeing Products
Feb 06, 2023 11:03 am ET
CSE Bulletin: Suspensions (BLMH, EGFV, GHG, GHG.WT, GPK, LVT, PPK)
Toronto, Ontario--(Newsfile Corp. - le 6 février/February 2023) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.
Feb 06, 2023 07:11 am ET
IIROC Trading Halt - LVT
VANCOUVER, BC, Feb. 6, 2023 /CNW/ - The following issues have been halted by IIROC:
Feb 01, 2022 04:05 pm ET
Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”) is pleased to announce the Company has appointed Philip van den Berg as Chief Executive Officer and to the Board of Directors replacing Mr. Pouya Farmand who will be...
Jan 18, 2022 04:15 pm ET
Levitee Labs Announces Non-Brokered Private Placement of up to $3,000,000
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that it is proposing to complete a...
Jan 12, 2022 08:00 am ET
Levitee Labs Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce the execution of a distribution agreement (the...
Jan 10, 2022 08:00 am ET
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the “Company” or “Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that the Company has entered into a strategic...
Jan 06, 2022 12:32 pm ET
CORRECTION - Levitee Labs Announces Medical Advisory Board
In a press release issued earlier today under the same headline by Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7), please be advised that the Levitee Labs Medical Advisory Board does not include Dr. Pamela J. Simms-Mackey, MD, FAAP, as...
Jan 06, 2022 08:00 am ET
Levitee Labs Announces Medical Advisory Board
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the “Company” or “Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, today announces the formation of a Medical Advisory Board consisting...
Dec 20, 2021 08:00 am ET
Levitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, Canada
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, today announces a new strategic collaboration with the LiveRx...
Nov 25, 2021 02:19 pm ET
Stocks2Watch's Virtual Investor Luncheon Agenda Updated for Tuesday November 30
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2021) - Stocks2Watch Investor Series today announced their agenda is updated for the Virtual Investor Luncheon on Tuesday November 30. Individual investors, finance professionals, and analysts are invited to register now to attend the Luncheon.
Nov 18, 2021 01:42 pm ET
Stocks2Watch to Host Investor Luncheon with Special Guest, Bruce Campbell from StoneCastle Investment Management, Tuesday November 30th
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - Stocks2Watch Investor Series today announced their agenda is set for the Investor Luncheon with Special Guest, Bruce Campbell from StoneCastle Investment Management, Tuesday November 30. Individual investors, institutional investors, advisors, and analysts are invited to register now to attend the Luncheon.
Nov 15, 2021 08:00 am ET
Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, today announces the appointment of Noha ElSayed, B.Sc.Pharm, APA, as...
Nov 10, 2021 08:00 am ET
Levitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British Columbia
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, has signed a letter of intent (“LOI”) to acquire 100% of the issued...
Nov 08, 2021 04:00 pm ET
Levitee Labs Publishes First Combined Revenue Figures for September 2021 and October 2021
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee Labs”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to publish revenue figures for the month of September...
Nov 08, 2021 08:00 am ET
Levitee Labs Signs LOI to Acquire Controlling Interest in a R&D Compounding Pharmacy; Focus to be on Levitee-Branded Products
Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, has signed a letter of intent (“LOI”) to acquire 51% of the issued...
Nov 05, 2021 08:00 am ET
Levitee Labs Announces Gold Sponsorship of Wonderland Psychedelic Conference in Miami
Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT), (OTC: LVTTF), (FSE: 7H7) an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce its participation as a Gold Sponsor at...
Oct 28, 2021 08:00 am ET
Levitee Clinics and Levitee Pharmacies Provide Insight on Integrated Acquisition Strategy for its Addiction and Pain Services
Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT), (OTC: LVTTF), (FSE: 7H7) an integrative wellness company with a diversified portfolio of healthcare and wellness assets, today provides additional information on its corporate growth...
Oct 21, 2021 08:00 am ET
Levitee Labs Enters into Credit Facility For Up To $12 Million
Levitee Labs Inc. (CSE: LVT) (OTCMKTS: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to report that it has entered into a financing...
Oct 18, 2021 08:30 am ET
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions
Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce a partnership with Adracare Inc....
Oct 14, 2021 08:45 am ET
Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada
Levitee Labs Inc. (the “Company” or “Levitee Labs”) (CSE: LVT); (OTCPK: LVTTF); (FSE: 7H7), an integrated wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce the appointment of Mohammed H. Mosli,...
Oct 12, 2021 08:45 am ET
Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacy
Levitee Labs Inc. (CSE: LVT) (OTCMKTS: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, has signed a letter of intent to acquire 51% of the issued and...
Oct 05, 2021 10:29 am ET
Levitee Labs Publishes First Revenue Figures for August 2021
Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to publish revenue figures for the month of August 2021. On a consolidated...
Oct 01, 2021 11:25 am ET
Levitee Labs Announces Listing On Frankfurt Stock Exchange
Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT); (OTCPK: LVTTF); (FSE: 7H7), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that its Common Shares were accepted...
Sep 24, 2021 08:45 am ET
Levitee Labs Announces DTC Eligibility Approval
Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT) (OTCPK: LVTTF), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that it’s common shares are now eligible for...
Sep 09, 2021 08:30 am ET
Levitee Labs Commences Trading in U.S. Under Ticker LVTTF
Levitee Labs Inc. (the “Company” or “Levitee Labs”) (CSE: LVT) (OTCPK: LVTTF), an integrated wellness company with a diversified portfolio of healthcare and wellness assets, announces that the Company has commenced trading in the United States on...
Aug 10, 2021 02:45 am ET
Levitee Labs Announces Azim Qazi as Head of Ecommerce and Consumer Packaged Goods
Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce Azim Qazi, MBA, MCIPS, P.Log, as Head of Ecommerce and Consumer...
Aug 05, 2021 08:45 am ET
Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer
Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce the appointment of Dr. Fady Hannah-Shmouni, a leading expert in...
Aug 04, 2021 09:00 am ET
Levitee Labs Completes Acquisition of Earth Circle Organics, Adds Superfoods Company to Portfolio
Levitee Labs Inc. (CSE: LVT) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that it has completed the acquisition of all the issued and...
Jul 29, 2021 09:15 am ET
Levitee Labs Acquires Three Specialized Alberta Pharmacies
Levitee Labs Inc. (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that, effective today, it has completed the acquisition of all the issued and...
Jul 29, 2021 09:00 am ET
Levitee Labs Acquires Five Addiction Clinics in Alberta
Levitee Labs Inc. (CSE: LVT) (the "Company" or "Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, today announces the completion of the acquisition of the majority of the operating assets of...
Jul 28, 2021 10:52 am ET
Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform
Levitee Labs Inc. (CSE: LVT) (the "Company" or "Levitee”), a biotechnology company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that it has completed the acquisition of all the issued and outstanding shares...
Jul 23, 2021 08:45 am ET
Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta
Levitee Labs Inc. (CSE: LVT) ("Levitee" or the "Company"), an integrative wellness company, is pleased to announce that it has executed the following definitive agreements (collectively, the "Agreements"): Asset purchase agreement to acquire all...
Jul 19, 2021 09:42 pm ET
CSE Bulletin: New Listing - Levitee Labs Inc. (LVT)
Toronto, Ontario--(Newsfile Corp. - Le 19 juillet/July 2021) - The common shares of Levitee Labs Inc. have been approved for listing on the CSE.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
